NYSE: FFFuturefuel Corp Stock
$4.14+0.27 (+6.98%)
Updated Jun 13, 2025
FF Price
$4.14
Fair Value Price
N/A
Market Cap
$181.35M
52 Week Low
$3.77
52 Week High
$6.40
P/E
-27.6x
P/B
0.96x
P/S
0.84x
PEG
N/A
Dividend Yield
5.8%
Revenue
$202.60M
Earnings
-$6.47M
Gross Margin
0%
Operating Margin
-3.04%
Profit Margin
-3.2%
Debt to Equity
0.21
Operating Cash Flow
$32M
Beta
0.82
Next Earnings
N/A
Ex-Dividend
Jun 4, 2025
Next Dividend
Jun 18, 2025
FF Overview
FutureFuel Corp. produces chemicals and biofuels. The chemical segment produces chemicals for specific customers and multi-customer specialty chemicals. The biofuel segment produces biodiesel and petrodiesel. The company was founded in 2005 and is headquartered in Clayton, MO.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FF's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important FF news, forecast changes, insider trades & much more!
FF News
Overview
Due Diligence Score
–
Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FF scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FF is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FF is good value based on its book value relative to its share price (0.96x), compared to the US Specialty Chemicals industry average (3.29x)
P/B vs Industry Valuation
FF is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more FF due diligence checks available for Premium users.
Valuation
FF price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-27.6x
Industry
10.29x
Market
31.36x
FF price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.96x
Industry
3.29x
FF is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FF's financial health
Profit margin
Revenue
$17.5M
Net Income
-$17.6M
Profit Margin
-100.6%
FF's Earnings (EBIT) of -$6.17M... subscribe to Premium to read more.
Interest Coverage Financials
FF's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$227.7M
Liabilities
$39.3M
Debt to equity
0.21
FF's short-term assets ($143.38M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FF's short-term assets ($143.38M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FF's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FF's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$5.4M
Investing
-$4.1M
Financing
-$3.0M
FF's operating cash flow ($31.62M)... subscribe to Premium to read more.
Debt Coverage Financials
FF vs Specialty Chemical Stocks
Futurefuel Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.